Tourette Syndrome Drug Market to Witness Growth Acceleration by 2028

The Tourette Syndrome Drug Market size is expected to grow at an annual average of CAGR 9% during the forecast period (2022-2028). Tourette’s syndrome is a neuropsychiatric disorder characterized by physical and vocal tics. Tics are repetitive, irregular movements of individual muscle groups and are formed due to genetic mutations that interfere with the production of histamine in the brain. Tourette’s syndrome is mainly caused by a disturbance in the balance of neurotransmitters in the brain that transmit nerve signals from cell to cell. This syndrome is associated with a feeling of obscene or socially inappropriate speech. Tourette’s syndrome is a genetic disorder that affects children and adolescents. Tourette’s syndrome also increases the risk of hyperactivity disorder or obsessive-compulsive disorder in children. Blinks, grimaces, convulsions, and stomping are some symptoms of Tourette’s syndrome. Drugs that target histamine receptors help treat this disorder. Currently, there is no single drug approved for the treatment of Tourette’s syndrome. However, current treatments help manage tics or other related symptoms caused by the syndrome.

The following segmentation are covered in this report:

By Drug Class

• Antiadrenergic Agents
• Antipsychotic Agents
• Atypical Antipsychotics
• Carbonic Anhydrase Inhibitor Anticonvulsants
• Others

By Distribution Channel

• Hospital pharmacies
• Retail pharmacies
• Online pharmacies

Company Profile

• AstraZeneca Plc
• Boehringer Ingelheim International GmbH
• Eli Lilly and Co.
• Lundbeck AS
• Johnson & Johnson Services Inc.
• Mylan NV
• Otsuka Holdings Co. Ltd.
• Pfizer Inc.
• Sun Pharmaceutical Industries Ltd.
• Teva Pharmaceutical Industries Ltd.

Scope of the report

The research study analyses the Tourette Syndrome Drug Market industry from 360-degree analysis of the market thoroughly delivering insights into the market for better business decisions, considering multiple aspects some of which are listed below as:

Recent developments

• Market overview and growth analysis
• Import and export overview
• Volume analysis
• Current market trends and future outlook
• Market opportunistic and attractive investment segment

Geographic coverage

• North America market size and/or volume
• Latin America market size and/or volume
• Europe market size and/or volume
• Asia-pacific market size and/or volume
• Rest of the world market size and/or volume

Key Questions Answered by Tourette Syndrome Drug Market Report

• What was the Tourette Syndrome Drug Market size in 2022 and 2028; what are the estimated growth trends and market forecast (2022-2028)
• What will be the Tourette Syndrome Drug Market CAGR of Market during the forecast period (2022-2028)?
• Which segments (product type/applications/end-user) were most attractive for investments in 2022? How these segments are expected to grow during the forecast period (2022-2028).
• Which manufacturer/vendor/players in the Tourette Syndrome Drug Market was the market leader in 2022?
• Overview on the existing product portfolio, products in the pipeline, and strategic initiatives taken by key vendors in the market.